We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+15.21%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$436B
AUM Growth
+$83.7B
Cap. Flow
+$35.4B
Cap. Flow %
8.11%
Top 10 Hldgs %
42.78%
Holding
5,681
New
461
Increased
2,914
Reduced
1,346
Closed
463

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.6B
2
AVGO icon
Broadcom
AVGO
+$1.11B
3
QQQ icon
Invesco QQQ Trust
QQQ
+$882M
4
JPM icon
JPMorgan Chase
JPM
+$628M
5
TSLA icon
Tesla
TSLA
+$594M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 7.37%
3 Consumer Discretionary 6.6%
4 Communication Services 5.05%
5 Healthcare 4.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACCD
5501
DELISTED
Accolade Inc
ACCD
-107,809
Closed -$753K
LGTY
5502
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
-39,001
Closed -$556K
NVRO
5503
DELISTED
NEVRO CORP.
NVRO
-51,151
Closed -$299K
ITCI
5504
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-27,000
Closed -$3.56M
ITCI
5505
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-49,003
Closed -$6.46M
ITCI
5506
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-27,000
Closed -$3.56M
TBNK
5507
DELISTED
Territorial Bancorp Inc.
TBNK
-14,548
Closed -$122K
VOXX
5508
DELISTED
VOXX International Corporation Class A
VOXX
-6,543
Closed -$49.1K
HAPR
5509
DELISTED
Innovator Premium Income 9 Buffer ETF - April
HAPR
-5,859
Closed -$146K
XDAP
5510
DELISTED
Innovator U.S. Equity Accelerated ETF - April
XDAP
-4,069
Closed -$145K
PTVE
5511
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
-60,596
Closed -$1.09M
SASR
5512
DELISTED
Sandy Spring Bancorp Inc
SASR
-113,072
Closed -$2.96M
VBFC
5513
DELISTED
Village Bank and Trust Financial Corp.
VBFC
-20
Closed -$684
FBMS
5514
DELISTED
The First Bancshares, Inc.
FBMS
-68,172
Closed -$2.09M
SBT
5515
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
-20,986
Closed -$102K
CUTR
5516
DELISTED
Cutera, Inc.
CUTR
-53
Closed
VMCAW
5517
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
-250,000
Closed -$17.5K
NKLA
5518
DELISTED
Nikola Corporation Common Stock
NKLA
-11
Closed -$2
OMGA
5519
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
-13,278
Closed -$1.08K
ME
5520
DELISTED
23andMe Holding Co
ME
-11,887
Closed -$8.79K
TTOO
5521
DELISTED
T2 Biosystems, Inc
TTOO
-1
Closed
GOEV
5522
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-93
Closed -$11
VCSA
5523
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
-9,597
Closed -$51.6K
ML
5524
DELISTED
MoneyLion Inc.
ML
-11,308
Closed -$978K
SWI
5525
DELISTED
SolarWinds Corporation Common Stock
SWI
-84,854
Closed -$1.56M

Similar funds

Barclays's Q2 2025 Portfolio in Review

As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.

  • Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
  • Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
  • Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
  • Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
  • Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
  • Barclays opened 461 new positions and closed 463 in Q2 2025.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $436B.

Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.